Journals / Türk Klinik Biyokimya Dergisi / 2019 / Cilt: 17 - Sayı: 1

The Relation Between Plasma 25-Hydroxy Vitamin D3 Levels, Disease Activity and Inflammatory Markers in Behçet Disease

Behçet Hastalığında Plazma Vitamin D3 düzeylerinin Hastalık Aktivitesi ve İnflamasyon Belirteçleri ile ilişkisi

Pages
1–9
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, associations were not found between 25-hydroxyvitamin D3 levels and disease activity as well as ESR and CRP in the Behcet Disease patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Autoimmunity is an important factor in the pathogenesis of Behcet Disease emphasized in recent years In recent studies, Vitamin D has been demonstrated to play a significant role in immune system functioning.
📊
Key Findings & Data:The measurement of plasma 25-hydroxyvitamin D3 levels, is accepted as a clinical indicator of vitamin D status.
💡
Conclusion & Impact:However, associations were not found between 25-hydroxyvitamin D3 levels and disease activity as well as ESR and CRP in the Behcet Disease patients.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Autoimmunity is an important factor in the pathogenesis of Behcet Disease emphasized in recent years In recent studies, Vitamin D has been demonstrated to play a significant role in immune system functioning. The measurement of plasma 25-hydroxyvitamin D3 levels, is accepted as a clinical indicator of vitamin D status. This study aimed to investigate plasma levels of 25-hydroxyvitamin D3 in patients with Behcet disease and to evaluate their raltionship to disease activity and inflammmatory markers. Material and Methods: Twenty eight active Behcet Disease and fourty eight inactive Behcet Disease patients diagnosed according to the International Study Group Criteria for Behcet Disease and fourty two healthy volunteers as control group were included in this study. They were recruited from the impatient and outpatient clinics of Dermatology of Okmeydani educational and researching hospitals in the period between March 2016 and June 2016. The erythrocyte sedimentation rate (ESR) was determined according to the Westergren method and C-reactive protein (CRP) by turbidimetric method. 25-hydroxyvitamin D3 levels were determined by Liquid chromatography tandem mass spectrometry. Statistical analysis of data was performed with SPSS 17.0.1 package program.Results: Plasma 25-hydroxyvitamin D3 levels of active, inactive patients and controls were 13,25±8,8 ng/mL, 11,06 ng/mL and 21,99±6 ng/mL respectively. In patients with Behcet’s Disease, 25- hydroxyvitamin D3 values were significantly lower than those of the healthy controls (p0,05). Significant negative correlations of plasma 25-hydroxyvitamin D3 levels with ESR and CRP were found in the inactive Behcet Diseases ( CRP r= -0,426 p=0,007, ESR r= -0,340 p=0,034).Conclusion: As the result of this study, plasma levels of 25-hydroxyvitamin D3 were significantly low in Behcet Disease patients compared to control groups. On account of our study suggests that deficiency of 25-hydroxyvitamin D3 may be predisposition factor for Behcet Disease. However, associations were not found between 25-hydroxyvitamin D3 levels and disease activity as well as ESR and CRP in the Behcet Disease patients.

Özet

Amaç: Otoimmünite, Behçet Hastalığı patogenezinde son yıllarda üzerinde durulan önemli bir faktördür. Son çalışmalarda Vitamin D’nin immün sistem fonksiyonu için de önemli olabileceği gösterildi. Serum 25-Hidroksi Vitamin D3 ölçümü vücuttaki vitamin D durumunun en iyi belirteçi olarak kabul edilmektedir. Bu çalışmada, aktif ve inaktif Behçet hastalarında 25- Hidroksi Vitamin D3 düzeylerini karşılaştırarak, 25-Hidroksi Vitamin D3’ün hastalık aktivitesiyle ve inflamasyon belirteçleriyleilişkisini incelemeyi amaçladık.Gereç ve Yöntem: Çalışmaya Mart 2016- Haziran 2016 tarihleri arasında Hastanemizin Dermatoloji polikliniğine başvurup tanısı Uluslararası Çalışma Grubu Tanı Kriterleri esas alınarak konulan 28 aktif, 39 inaktif Behçet hastası ile 32 sağlıklı kontrol grubu olmak üzere toplam 95 olgu dahil edildi. Serum Creaktif protein düzeyleri turbidimetrik; eritrosit sedimantasyon hızı Westergren, 25- Hidroksi Vitamin D3 ise likit kromotografi tandem kütle spektrometri yöntemi ile ölçüldü. Verilerin istatistiksel analizi SPSS 17.0.1 paket programı ile yapıldı.Bulgular: Plazma 25-Hidroksi Vitamin D3 düzeyi Aktif Behçet hastalarında ortalama 13,25±8,8 ng/mL, inaktif Behçet hastalarında ortanca 11,06 ng/mL ve kontrol grubunda 21,99±6 ng/mL bulundu. Aktif Behçet ve İnaktif Behçet hasta grubunda plazma 25-Hidroksi Vitamin D3 konsantrasyonları kontrol grubuna göre anlamlı derecede düşük bulundu.(p0,05) İnaktif Behçet hastalarında 25 Hidroksi Vitamin D3 düzeyi ile CRP ve Eritrosit Sedimantasyon hızı arasında negatif korelasyon bulundu. (CRP için r= -0,426 p=0,007, ESR için r= - 0,340 p=0,034)Sonuç: Çalışmamızda plazma 25 Hidroksi Vitamin D3 düzeylerini Behçet hastalarında kontrol grubuna göre anlamlı derecede düşük saptadık. Bu sonuç Vitamin D eksikliğinin Behçet Hastalığı için predispozan faktör olabileceğini düşündürmektedir. Ayrıca Behçet hastalarında 25 Hidroksi Vitamin D3düzeyi ile hastalık aktivitesi ve inflamasyon belirteçleri arasında ilişki bulunamadı.

🔖

Cite This Article

SİNGER, R., DURMUŞCAN, M., VARDAR, M., SUCU, V. (2022). The Relation Between Plasma 25-Hydroxy Vitamin D3 Levels, Disease Activity and Inflammatory Markers in Behçet Disease. Türk Klinik Biyokimya Dergisi, Cilt: 17 - Sayı: 1, 1–9. https://ajindex.com/articles/634344

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Alpsoy E. Behçet’s disease: treatment of mucocutaneous lesions: Clin Exp Rheumatol 2005;23:532-9
  2. Azizlerli G, Köse AA, Sarica R, et al. Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol 2003;42:803-6
  3. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behcet’s disease: an analysis of 2147 patients. Yonsei Med J 1997;38:423-7
  4. Akman A, Alpsoy E. Behcet’s Disease: Current Aspects in the Etiopathogenesis. Turkderm-Archives of the Turkish Dermatology and Venerology 2009;43(Suppl.2):32-8
  5. Akman A, Alpsoy E. Behçet Hastalığı: Etyopatogenezde Güncel Bilgiler. Türkderm 2009; 43 Özel Sayı 2: 32–38 6. Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H. Involvement ofchemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions ofBehçet’s disease. Arthritis Rheumatism 2004; 50: 2291–2295
  6. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancer and cardiovascular disease. Am J Clin Nutr 2004; 80(6 suppl): S1678-88
  7. Ward LM. Vitamin D deficiency in the 21st century: a persistent problem among Canadian infants and mothers. CMAJ 2005; 172:769- 70
  8. Holick MF. The Vitamin D epidemic and its health consequences. J Nutr 2005; 135:2739-48
  9. Heaney RP. Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr 2003; 78: 912- 9
  10. Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heartdisease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 2005; 98: 1024- 7
  11. Tetlow LC, Smith SJ, Mawer EB, Woolley DE. Vitamin D receptors in therheuamatoid lesion:expression by chondrocytes, macrophages and synoviocytes. Ann Rheum Dis 1999;58:11821
  12. Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D ontype 1mediated immunity. Mol Aspects Med 2008;29:369-75
  13. Van EE, Mathieu C. Immunoregulation by 1,25- dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97:93–101
  14. Müftüoğlu AU, Yazici H, Yurdakul S, Tüzün Y, Pazarli H, Güngen G, et al, Behçet's Disease. Relation of Serum C- reactive Protein and Erythrocyte Sedimentation Rates to Disease Activity. Int J Dermatol 1986;25:235-239
  15. Bayazıt N, Yılmaz M, Oral B, Tokgöz N, Yücel A, Sarıcaoğlu H, Tunalı Ş: Behçet Hastalığında immünolojik aktivasyon belirteçleri. Türk Dermatoloji Dergisi 2008;2 (2): 34-8
  16. Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A. Vitamin D modulates peripheral immunity in patients with Beh